The effects of nicotine (54115) and sidestream tobacco smoke (STS) on pregnancy outcome were studied in rats. Nicotine delivering transdermal patches were attached to the shaved backs of pregnant Sprague-Dawley-rats from day two to seven or day two to 19 of gestation, which corresponded to the first trimester or the complete gestational period, respectively. The patches were cut to deliver nicotine at the rate of 1.75 or 3.5 milligrams per day (mg/day). Controls were given a placebo patch. Other pregnant rats were exposed to STS from research cigarettes from days three to 11 of gestation. The STS concentration was equivalent to 1mg/m3 total suspended particulate material. The rats that received the nicotine patches were killed on gestational day 19 and those exposed to STS were killed on gestational day 20. The uteri were removed and examined. The number of live and dead fetuses were counted. The fetuses were weighed. Maternal blood samples were collected and analyzed for plasma nicotine and cotinine (486566). A 100% pregnancy failure rate, no fetuses being found, occurred in dams exposed to the 3.5mg/day nicotine patches during the entire gestational period. A 50% pregnancy failure rate was seen in rats exposed to the 3.5mg/day patches during the first trimester. In rats exposed to the 1.75mg/day patches, a 50% pregnancy failure rate occurred in those exposed during the entire gestational period. Exposure for the first trimester only had no effect on pregnancy outcome. Fetal weights were not affected by the nicotine patches. No nicotine or cotinine was detected in the plasma of rats exposed to the nicotine patches during the first trimester. The number of live fetuses per litter was significantly decreased by exposure to STS. The authors conclude that continuous exposure to nicotine during pregnancy may adversely affect pregnancy outcome in rats.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.